From WebMD · · 1m 10s
FDA approves Rhapsido for hives from skin rubbing
The FDA has approved Rhapsido for symptomatic dermographism, a condition where skin rubbing triggers severe itching and hives in adults whose symptoms don't respond to standard allergy medicines.
In brief
The FDA has approved Rhapsido for symptomatic dermographism, a condition where skin rubbing triggers severe itching and hives in adults whose symptoms don't respond to standard allergy medicines. The FDA approved Rhapsido for adults with symptomatic dermographism, a condition causing hives when skin is rubbed, after a…
What is symptomatic dermographism
Symptomatic dermographism causes severe itchiness and raised hives when skin is rubbed, scratched, or pressed. It affects adults whose symptoms do not respond to H1 antihistamines, common allergy medicines.
How Rhapsido works
Rhapsido is a prescription pill that blocks a protein called Bruton's tyrosine kinase, or BTK.
Trial results for Rhapsido
A clinical trial of one hundred fifteen adults showed that at twelve weeks, twenty nine point three percent taking Rhapsido had hives completely clear up, compared to fourteen percent taking placebo.
“29.3% versus 14%”
How to take Rhapsido safely
Rhapsido comes as a tablet swallowed whole with water twice daily, with or without food.Do not crush, chew, or split tablets.
The takeaway
The FDA approved Rhapsido for adults with symptomatic dermographism, a condition causing hives when skin is rubbed, after a trial showed it cleared hives in twice as many patients as placebo.
